Article Versions Notes

Næss LM, Vanderven H, Bryant-Bratlie D, Laake I, Pleguezuelos O, Oftung F. FLU-v, a Broad-Spectrum Peptide-Based Influenza Vaccine, Induces NK Cell Activating IgG1 and IgG3 Subclass Antibodies in Humans. Vaccines. 2025; 13(11):1084. https://doi.org/10.3390/vaccines13111084

Næss, Lisbeth M., Hillary Vanderven, Diane Bryant-Bratlie, Ida Laake, Olga Pleguezuelos, and Fredrik Oftung. 2025. "FLU-v, a Broad-Spectrum Peptide-Based Influenza Vaccine, Induces NK Cell Activating IgG1 and IgG3 Subclass Antibodies in Humans" Vaccines 13, no. 11: 1084. https://doi.org/10.3390/vaccines13111084

Næss, L. M., Vanderven, H., Bryant-Bratlie, D., Laake, I., Pleguezuelos, O., & Oftung, F. (2025). FLU-v, a Broad-Spectrum Peptide-Based Influenza Vaccine, Induces NK Cell Activating IgG1 and IgG3 Subclass Antibodies in Humans. Vaccines, 13(11), 1084. https://doi.org/10.3390/vaccines13111084